IRIB Normandy Rouen / Institute for Research and Innovation in Biomedicine
Registration
Symposium IRIB: 4th OncoThera colloquium - 18/03/2019
L’Institut de Recherche et d’Innovation Biomédicale (IRIB) a le plaisir de vous inviter
le lundi 18 mars
au 4ème symposium OncoThera
sur le thème "Cellular immunotherapy of cancer at age of maturity".
Organisateurs: Olivier Boyer et Jean-Baptiste Latouche (Inserm UNIROUEN UMR 1234)
Sponsors : IRIB, Amgen, Miltényi, Dutscher, Cancéropôle Nord-Ouest
 |
 |
 |
 |
 |
Inscription obligatoire : close.
L'accueil et le déjeuner se déroulent dans la Salle de Réception des thèses au 6ème étage du Bâtiment Stewart. Faculté de Médecine et Pharmacie - 14 rue du Professeur Stewart 76042 ROUEN CEDEX Le Symposium aura lieu dans l'amphi 110 au 1er étage du Bâtiment Stewart.
| Program | ||
| 12h30 | Welcome reception (6th floor) | |
| 13h40 | Laurent Yon (Vice-President of the University of Rouen) Welcome foreword | |
| 13h45 | Véronique Desjardins (Director of Rouen University Hospital) – Welcome foreword | |
| 13h50 | Laurent Poulain (Caen) - Presentation of OncoThera | |
| 13h55 | Olivier Boyer (Rouen) - Introduction to the symposium | |
| CAR T cells and BITEs | Chairman: Ibrahim Yakoub-Agha (Lille) | |
| 14h00-14h40 | Renier Brentjens (MSKCC, New York) | |
| CARs and armored CARs: moving T cell therapy forward | ||
| 14h40-15h20 | Monica Guzman (Weill Cornell, New York) | |
| CAR T cells for leukemia therapy: targeting malignant stem cells | ||
| 15h20-15h40 | Christophe Ferrand (Besançon, Inserm U1098) | |
| IL-1RAP as a candidate leukemia target for CAR T cells | ||
| 15h40-15h50 | Gaëtan Riou (Rouen, Inserm U1234) | |
| Single or not single dose, that is the question? | ||
| 15h50-16h00 | Alessandra Brescianini (Amgen, Onco-hematology) | |
| BITE, linking cells for therapy | ||
| 16h00-16h30 | Coffee break | |
| T cell immunotherapy | Chairman: Olivier Boyer (Rouen) | |
| 16h30-16h50 | Jean-Baptiste Latouche (Rouen, Inserm U1234) | |
| AAPC for cancer immunotherapy | ||
| 16h50-17h10 | José Cohen (Créteil, Inserm CIC 1430 Henri Mondor) | |
| Targeting TNFR2 to improve antitumor effect | ||
| 17h10-17h30 | Sébastien Maury (Créteil, Inserm U955) | |
| Treg depletion for DLI | ||
| 17h30-18h00 | Round table | |
| Trends and expectations in cellular immunotherapy of cancer | ||
| 18h00 | End of meeting | |